病患者的抗血栓药物:适当性和风险效益分析
A J Bethurum1, Kevin Zeng1, Thaddeus Puzdrakiewicz1
1Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
The American surgeon
|March 27, 2024
概括
跌倒是老年人住院的主要原因之一. 这项研究发现,在许多秋季患者中,抗血栓治疗的风险可能超过益处,强调需要仔细审查药物治疗的必要性.
科学领域:
- 老年病的医生 老年病的医生
- 创伤外科 手术 创伤外科
- 心脏病学 心脏病学
背景情况:
- 跌倒是美国与创伤相关的住院病例的主要原因,在2020年有超过300万例住院病例.
- 老年患者是跌倒的常见人群,他们经常被处方抗血栓 (AT) 治疗.
研究的目的:
- 分析从地面下跌 (GLF) 后出现的患者的跌倒史.
- 评估抗血栓治疗方案相对于个体跌倒风险的适当性.
主要方法:
- 一项前性研究,在地面下跌后招募患者.
- 主要结局:AT治疗的必要性 (CHA 2 DS 2 -VASc评分) 和跌倒风险 (莫尔斯跌倒风险评分) 之间的相关性.
主要成果:
- 该队列包括30名患者,平均年龄为77岁.
- 在CHA2DS2 -VASc和莫尔斯跌倒风险得分之间观察到适度的正相关性 (r = 0.47;P = 0.012).
- 值得注意的是,17%的高跌倒风险患者的静脉血栓栓塞 (VTE) 一年风险低于5%.
结论:
- 在大量患者中,出血的风险可能超过血栓塞栓预防的益处,在大量患者中,出血是在跌倒后出现的.
- 这项研究强调了老年人群中大量的跌倒,以及在这种情况下重新评估AT治疗的必要性.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Pre-Procedural Guidelines for Assessing Blood Pressure
563
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
563
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424


